Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension

Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G (1991) Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 260:R817-823 Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ (1988) Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 81:213–220 Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G (2003) Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60:1327–1332 Guo L, Esler MD, Sari C, Phillips S, Lambert EA, Straznicky NE, Lambert GW, Corcoran SJ (2018) Does sympathetic dysfunction occur before denervation in pure autonomic failure? Clin Sci (Lond) 132:1–16 Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2020) Baroreflex Dysfunction. N Engl J Med 382:163–178 Lo A, Norcliffe-Kaufmann L, Vickery R, Bourdet D, Kanodia J (2021) Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension. Clin Auton Res. https://doi.org/10.1007/s10286-021-00800-x Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD (1992) Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 19:628–633 Nelson JC, Jatlow PI, Bock J, Quinlan DM, Bowers MB Jr (1982) Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics. Arch Gen Psychiatry 39:1055–1061 Palma JA, Kaufmann H (2020) Management of orthostatic hypotension. Continuum (Minneap Minn) 26:154–177 Palma JA, Mano T (2018) Central or peripheral autonomic dysfunction in Parkinson disease: does it matter? Neurology 90:1045–1046 Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H (2018) Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. Neurology 91:e1539–e1544 Ramirez CE, Okamoto LE, Arnold AC, Gamboa A, Diedrich A, Choi L, Raj SR, Robertson D, Biaggioni I, Shibao CA (2014) Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension 64:1235–1240 Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, Robertson D, Biaggioni I (2007) Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension 50:47–53 Smith JA, Bourdet DL, Daniels OT, Ding YS, Gallezot JD, Henry S, Kim KH, Kshirsagar S, Martin WJ, Obedencio GP, Stangeland E, Tsuruda PR, Williams W, Carson RE, Patil ST (2014) Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Int J Neuropsychopharmacol 18:pyu027